Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multi-center, Open Label Study of Subcutaneous Secukinumab in Prefilled Syringes as Mono- or Co-therapy to Assess the Efficacy, Safety and Tolerability up to 52 Weeks in Japanese Subjects With Gener
Brief Summary: The purpose of this study is to assess efficacy and safety data of secukinumab in Japanese subjects with generalized pustular psoriasis (GPP). This study is expected to support the filing of secukinumab in the indication of pustular psoriasis in Japan.